2016 Targeted Radiotherapy Workshop

2016 NCI SBIR Workshop on Facilitating the Development of Molecularly Targeted Radiotherapy 

November 10, 2016

National Cancer Institute Shady Grove Campus, Rockville, MD

As part of its continued effort to support awardee companies' journey to commercialization, NCI SBIR Development Center hosted a specialized workshop for awardee complanies developing molecularly targeted radiotherapy. The Workshop on Facilitating the Development of Molecularly Targeted Radiotherapy (hereinafter TRT Workshop) brought together experts from the SBIR program, NCI Radiation Research program, Food and Drug Administration's Center for Drug Evaluation and Research (FDA CDER), and Department of Energy's Isotope program to introduce the regulatory and clinical processes relevant to workshop participants.

Workshop Agenda:

9:00 - 9:15    Welcome from Michael Weingarten, Director NCI SBIR

9:15 – 9:25   Introduction to the Workshop’s Objectives, Deepa Narayanan (NCI SBIR)

9:25-10:45    Awardee Introductions (2-3 minutes per awardee organization). Each awardee

                        organization will provide a quick introduction of their company/institution, basic             

                        technology, and their current project.

10:45-11:00  BREAK

11:00-11:45  Pre-clinical considerations for TRT technologies

                         Dr. Haleh Saber, Deputy Director, Division of Hematology Oncology Toxicology/ 

                         OHOP/CDER

11:45-12:30  Clinical considerations for TRT technologies

                         Dr. Amanda Walker, Medical Officer, Division of Oncology Products 1, CDER/FDA

12:30 -1:30   LUNCH/ NETWORKING

1:30-2:15      Information about DoE’s Isotope Program and Access to Isotopes

                       Dr. Marc Garland, Deputy Director, Department of Energy Isotope Program

2:15-2:30      BREAK

2:30-4:30      Interactive discussion with the DOE & FDA, Moderated by Dr.Jacek Capala (NCI RRP)

4:30-4:45      Closing Remarks